NCT01863706View on ClinicalTrials.gov

Misoprostol Versus Oxytocin for Prevention of Post Partum Hemorrhage

PHASE1CompletedINTERVENTIONAL
Enrollment

400

Participants

Timeline

Start Date

May 31, 2013

Primary Completion Date

December 31, 2013

Study Completion Date

December 31, 2013

Conditions
Post Partum Hemorrhage
Interventions
DRUG

Misoprostol

400µg oral misoprostol

DRUG

Oxytocin

20 IU Oxytocin

Trial Locations (1)

097145-3388

Hormozgan University of Medical Sciences, Bandar Abbas

All Listed Sponsors
lead

Hormozgan University of Medical Sciences

OTHER

NCT01863706 - Misoprostol Versus Oxytocin for Prevention of Post Partum Hemorrhage | Biotech Hunter | Biotech Hunter